Exodus Point Capital Management, LP Bausch Health Companies Inc. Call Options Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 19, 2022	SELL	$7.06 - $23.63 $2.12 Million - $7.09 Million	-300,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $4.86 Million - $6.25 Million	225,000 Added 300.0%	300,000 $6.86 Million
Q4 2021 Feb 11, 2022	SELL	$23.0 - $29.01 $1.73 Million - $2.18 Million	-75,000 Reduced 50.0%	75,000 $2.07 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $1.25 Million - $1.5 Million	-50,000 Reduced 25.0%	150,000 $4.18 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $1.37 Million - $1.64 Million	50,000 Added 33.33%	200,000 $5.87 Million
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $2.3 Million - $3.7 Million	107,500 Added 252.94%	150,000 $4.76 Million
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $2.41 Million - $3.33 Million	-157,500 Reduced 78.75%	42,500 $884,000
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $2.66 Million - $4.1 Million	200,000 New	200,000 $3.56 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.